Intersect ENT
XENT
$28.24
Share price
0.00%
Change (1 day)
17.72%
Change (1 year)
Categories
Earnings for Intersect ENT (XENT)
Earnings in 2021: -$0.17 B
According to Intersect ENT's latest financial reports the company's current earnings (TTM) are -$0.17 B. In 2021 the company made an earning of -$0.17 B a decrease over its 2020 earnings that were of -$72.74 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Intersect ENT from 2012 to 2021
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2021 | -$0.17 B | 121.8% |
| 2020 | -$72.74 M | 69.17% |
| 2019 | -$43 M | 87.57% |
| 2018 | -$22.93 M | 40.08% |
| 2017 | -$16.37 M | -35.12% |
| 2016 | -$25.23 M | -5.3% |
| 2015 | -$26.64 M | 45.05% |
| 2014 | -$18.37 M | -0.04% |
| 2013 | -$18.37 M | 12.25% |
| 2012 | -$16.37 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Ocular Therapeutix OCUL | -$80.74 M | -49.95% | 🇺🇸 USA |
 ICON plc ICLR | $0.62 B | -487.09% | 🇮🇪 Ireland |
 Anika Therapeutics ANIK | -$25.45 M | -84.23% | 🇺🇸 USA |
 Haemonetics HAE | $0.17 B | -205.50% | 🇺🇸 USA |